Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment.
Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study.
Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate to severe atopic dermatitis in clinical practice: A retrospective cohort study.
Guselkumab dosing interval optimization in adult patients with psoriasis: A retrospective, multicenter case series.
16280 Sixteen-week efficacy and safety results of 93 patients treated with dupilumab for moderate to severe atopic dermatitis.
16177 Assessment of conjunctivitis occurring in patients with long-term use of dupilumab for the treatment of atopic dermatitis in clinical practice.
15319 52-week evaluation of the efficacy of dupilumab for moderate to severe atopic dermatitis in clinical practice: A Canadian multicenter retrospective study.